Osmetech is betting the five-year deal will expand its sales and marketing efforts in the US and allow it to allocate more resources towards bringing its pipeline of tests to market.
Life Technologies announced today that it has been named to the FTSE4 Good Index Series, which includes companies that reach rigorous social, ethical, and environmental criteria.
Bruker, NextGen, Sigma-Aldrich, Bio-Rad, Waters, Pressure BioSciences, PSI, Xencor, Pfizer
The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.
Tepnel's shareholders will vote on the deal next month, with the $132.1 million offer expected to take effect in April.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.